Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62].

Lung Cancer

Thoracic Center, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo, 104-8560, Japan. Electronic address:

Published: June 2019

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.lungcan.2019.04.010	DOI Listing

Publication Analysis

gemcitabine cisplatin

corrigendum "necitumumab

"necitumumab gemcitabine

cisplatin versus

versus gemcitabine

cisplatin first-line

first-line treatment

treatment stage

stage squamous

squamous non-small

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!